Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 10 studies | 48% ± 26% | |
| endothelial cell | 8 studies | 27% ± 10% | |
| type I pneumocyte | 7 studies | 32% ± 13% | |
| oligodendrocyte precursor cell | 7 studies | 31% ± 14% | |
| GABAergic neuron | 6 studies | 45% ± 23% | |
| epithelial cell | 5 studies | 30% ± 14% | |
| astrocyte | 5 studies | 28% ± 8% | |
| type II pneumocyte | 5 studies | 22% ± 8% | |
| squamous epithelial cell | 4 studies | 34% ± 15% | |
| neuron | 4 studies | 26% ± 8% | |
| cardiac muscle cell | 4 studies | 20% ± 0% | |
| interneuron | 4 studies | 49% ± 24% | |
| GABAergic interneuron | 3 studies | 23% ± 4% | |
| granule cell | 3 studies | 23% ± 6% | |
| club cell | 3 studies | 23% ± 8% | |
| oligodendrocyte | 3 studies | 24% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 10 studies | 37% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2410.51 | 1445 / 1445 | 100% | 41.39 | 183 / 183 |
| intestine | 100% | 2672.03 | 966 / 966 | 99% | 26.16 | 524 / 527 |
| prostate | 100% | 2077.83 | 245 / 245 | 99% | 20.45 | 499 / 502 |
| stomach | 100% | 2194.90 | 359 / 359 | 99% | 31.36 | 284 / 286 |
| lung | 100% | 3050.80 | 577 / 578 | 99% | 23.24 | 1148 / 1155 |
| kidney | 100% | 1642.03 | 89 / 89 | 99% | 23.89 | 892 / 901 |
| pancreas | 100% | 2600.18 | 328 / 328 | 99% | 20.22 | 176 / 178 |
| breast | 100% | 1724.46 | 459 / 459 | 99% | 15.90 | 1103 / 1118 |
| bladder | 100% | 2207.71 | 21 / 21 | 98% | 18.24 | 496 / 504 |
| thymus | 100% | 2398.28 | 652 / 653 | 98% | 15.21 | 591 / 605 |
| uterus | 100% | 1838.82 | 170 / 170 | 96% | 14.81 | 442 / 459 |
| skin | 100% | 3235.33 | 1809 / 1809 | 96% | 15.25 | 453 / 472 |
| brain | 98% | 3624.59 | 2589 / 2642 | 98% | 18.77 | 688 / 705 |
| ovary | 100% | 1833.04 | 180 / 180 | 95% | 13.44 | 410 / 430 |
| liver | 100% | 1469.37 | 226 / 226 | 90% | 11.03 | 366 / 406 |
| adrenal gland | 100% | 3063.86 | 258 / 258 | 89% | 11.19 | 204 / 230 |
| muscle | 100% | 2825.43 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2082.87 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.77 | 1 / 1 |
| blood vessel | 100% | 1748.26 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 1609.69 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 19.05 | 44 / 45 |
| heart | 96% | 2553.80 | 826 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 92% | 1518.95 | 854 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 83% | 7.02 | 66 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 72% | 7.16 | 21 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0018105 | Biological process | peptidyl-serine phosphorylation |
| GO_0018107 | Biological process | peptidyl-threonine phosphorylation |
| GO_0032456 | Biological process | endocytic recycling |
| GO_0033572 | Biological process | transferrin transport |
| GO_0006468 | Biological process | protein phosphorylation |
| GO_0045022 | Biological process | early endosome to late endosome transport |
| GO_0046777 | Biological process | protein autophosphorylation |
| GO_0001881 | Biological process | receptor recycling |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0016020 | Cellular component | membrane |
| GO_0055037 | Cellular component | recycling endosome |
| GO_0005769 | Cellular component | early endosome |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0043025 | Cellular component | neuronal cell body |
| GO_0030426 | Cellular component | growth cone |
| GO_0106310 | Molecular function | protein serine kinase activity |
| GO_0004674 | Molecular function | protein serine/threonine kinase activity |
| GO_0004672 | Molecular function | protein kinase activity |
| GO_0004864 | Molecular function | protein phosphatase inhibitor activity |
| GO_0005524 | Molecular function | ATP binding |
| GO_0070853 | Molecular function | myosin VI binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | LMTK2 |
| Protein name | LMTK2 protein Alternative protein LMTK2 Serine/threonine-protein kinase LMTK2 (EC 2.7.11.1) (Apoptosis-associated tyrosine kinase 2) (Brain-enriched kinase) (hBREK) (CDK5/p35-regulated kinase) (CPRK) (Kinase/phosphatase/inhibitor 2) (Lemur tyrosine kinase 2) (Serine/threonine-protein kinase KPI-2) |
| Synonyms | BREK AATYK2 KPI2 LMR2 KIAA1079 |
| Description | FUNCTION: Phosphorylates PPP1C, phosphorylase b and CFTR. |
| Accessions | Q8IWU2 L8E8L1 A2VDI9 ENST00000297293.6 |